Terms: = Uterine cancer AND EZH2, ENX-1, 2146, ENSG00000106462, Q15910, MGC9169 AND Diagnosis
4 results:
1. Comparative analysis of ezh2, p16 and p53 expression in uterine carcinosarcomas.
Makk E; Bohonyi N; Oszter A; Éles K; Tornóczky T; Tóth A; Kálmán E; Kovács K
Pathol Oncol Res; 2023; 29():1611547. PubMed ID: 38146588
[No Abstract] [Full Text] [Related]
2. LncRNAs: key players and novel insights into cervical cancer.
Peng L; Yuan X; Jiang B; Tang Z; Li GC
Tumour Biol; 2016 Mar; 37(3):2779-88. PubMed ID: 26715267
[TBL] [Abstract] [Full Text] [Related]
3. ARID1A gene mutation in ovarian and endometrial cancers (Review).
Takeda T; Banno K; Okawa R; Yanokura M; Iijima M; Irie-Kunitomi H; Nakamura K; Iida M; Adachi M; Umene K; Nogami Y; Masuda K; Kobayashi Y; Tominaga E; Aoki D
Oncol Rep; 2016 Feb; 35(2):607-13. PubMed ID: 26572704
[TBL] [Abstract] [Full Text] [Related]
4. Influence of body size and body fat distribution on risk of uterine leiomyomata in U.S. black women.
Wise LA; Palmer JR; Spiegelman D; Harlow BL; Stewart EA; Adams-Campbell LL; Rosenberg L
Epidemiology; 2005 May; 16(3):346-54. PubMed ID: 15824551
[TBL] [Abstract] [Full Text] [Related]
